These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5572288)

  • 1. Explanation for the discrepancy in reported cardiac electrophysiological actions of diphenylhydantoin and lignocaine.
    Singh BN
    Br J Pharmacol; 1971 Feb; 41(2):385P-386P. PubMed ID: 5572288
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of altering potassium concentration on the action of lidocaine and diphenylhydantoin on rabbit atrial and ventricular muscle.
    Singh BN; Williams EM
    Circ Res; 1971 Sep; 29(3):286-95. PubMed ID: 5093288
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of aprindine and lidocaine on transmembrane potentials and radioactive K efflux in different cardiac tissues.
    Carmeliet E; Verdonck F
    Acta Cardiol; 1974; Suppl 18():73-90. PubMed ID: 4547403
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of diphenylhydantoin on electrophysiological properties of the canine heart.
    Rosati RA; Alexander JA; Schaal SF; Wallace AG
    Circ Res; 1967 Nov; 21(5):757-65. PubMed ID: 6073567
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiology and pharmacology of cardiac arrhythmias. II. Relationship of normal and abnormal electrical activity of cardiac fibers to the genesis of arrhythmias. A Automaticity.
    Wit AL; Rosen MR; Hoffman BF
    Am Heart J; 1974 Oct; 88(4):515-24. PubMed ID: 4606513
    [No Abstract]   [Full Text] [Related]  

  • 6. Inotropic actions of lignocaine and phenytoin.
    Kennedy BL; Nookhwun C; Sadavongvivad C; Tanchajja S
    Br J Pharmacol; 1971 Nov; 43(3):483-96. PubMed ID: 4110251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of lidocaine block of sodium channels in single human atrial cells.
    Jia H; Furukawa T; Singer DH; Sakakibara Y; Eager S; Backer C; Arentzen C; Wasserstrom JA
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1275-84. PubMed ID: 8383745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac effects of dehydrobenzperidol and fentanyl].
    Castañeda Casado J; Montero Jara V; García Fernández MR
    Rev Esp Anestesiol Reanim; 1979 Nov; 26(6):583-99. PubMed ID: 547317
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiologic effects of lidocaine in awake dogs.
    Sugimoto T; Schaal SF; Dunn NM; Wallace AG
    J Pharmacol Exp Ther; 1969 Mar; 166(1):146-50. PubMed ID: 5776017
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrophysiological actions of diphenylhydantoin on rabbit atria. Dependence on stimulation frequency, potassium, and sodium.
    Jensen RA; Katzung BG
    Circ Res; 1970 Jan; 26(1):17-27. PubMed ID: 5410092
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of different electrophysiological mechanisms for muscarinic inhibition of atria and ventricles.
    Pappano AJ; Inoue D
    Fed Proc; 1984 Aug; 43(11):2607-12. PubMed ID: 6745450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of quinidine, lidocaine and phenytoin on the excitability of the ischemic rabbit heart.
    Hondeghem LM
    Proc West Pharmacol Soc; 1976; 19():320-2. PubMed ID: 995999
    [No Abstract]   [Full Text] [Related]  

  • 13. Electrophysiological effects of direct current countershock before and after ouabain sensitization and after diphenylhydantoin desensitization in the dog.
    Helfant RH; Scherlag BJ; Damato AM
    Circ Res; 1968 May; 22(5):615-23. PubMed ID: 5648065
    [No Abstract]   [Full Text] [Related]  

  • 14. Actions of diphenylhydatoin on the electrical properties of isolated rabbit and canine atria.
    Strauss HC; Bigger JT; Bassett AL; Hoffman BF
    Circ Res; 1968 Sep; 23(3):463-77. PubMed ID: 5676455
    [No Abstract]   [Full Text] [Related]  

  • 15. The depressant action of diphenylhydantoin on electrical and mechanical properties of isolated rabbit and dog atria: dependence on sodium and potassium.
    Katzung BG; Jensen RA
    Am Heart J; 1970 Jul; 80(1):80-8. PubMed ID: 5426843
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
    Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
    J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo cardiac electrophysiologic effects of a novel diphenylphosphine oxide IKur blocker, (2-Isopropyl-5-methylcyclohexyl) diphenylphosphine oxide, in rat and nonhuman primate.
    Regan CP; Wallace AA; Cresswell HK; Atkins CL; Lynch JJ
    J Pharmacol Exp Ther; 2006 Feb; 316(2):727-32. PubMed ID: 16243963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of mexiletine on left ventricular ejection: a comparison with lignocaine and propranolol.
    Shaw TR
    Postgrad Med J; 1977; 53 Suppl 1():69-73. PubMed ID: 876955
    [No Abstract]   [Full Text] [Related]  

  • 19. Complications associated with rapid caffeine application to cardiac myocytes that are not voltage clamped.
    Zaniboni M; Yao A; Barry WH; Musso E; Spitzer KW
    J Mol Cell Cardiol; 1998 Nov; 30(11):2229-35. PubMed ID: 9925360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A bradycardic agent, UL-FS 49, increases atrial force and decreases ventricular force in isolated, perfused heart preparations of dogs.
    Furukawa Y; Takayama S; Sawaki S; Inoue Y; Chiba S
    J Pharmacol Exp Ther; 1993 May; 265(2):801-6. PubMed ID: 8496825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.